Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
Saved in:
| Title: | Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy? |
|---|---|
| Authors: | Du R; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Zhang J; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Lukas RV; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Tripathi S; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Ahrendsen JT; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA (J.T.A.).; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Curran MA; Department of Immunology, MD Anderson Cancer Center, the University of Texas, Houston, Texas, USA., Dmello C; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Zhang P; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Stupp R; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Rao G; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA., Heimberger AB; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Jan 12; Vol. 27 (1), pp. 33-49. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noae193 |
